ECOR electroCore Total Debt to Capital

ECOR (electrocore.com) - company brandmark

electroCore, Inc. is expanding its migraine therapy reach through alliances with digital medical centers and pharmacies, leveraging a streamlined internal warehouse system to ensure uninterrupted supplies. The market dynamics reflected in the price action on GURU.Markets show that the total debt-to-equity ratio is 0.00. The brand's financial stability is based on the sale of nerve stimulators and steady demand for ancillary consumables.

electroCore Medical - ECOR Debt to Capital (period 07/04/2022 - 10/27/2026)
Finished products of electroCore Inc

For electroCore, Inc., a developer of specialized neurostimulation equipment, the debt-to-equity ratio reflects the balance between borrowed capital and net assets. This metric measures the degree of financial leverage, allowing investors to assess insolvency risk or the efficiency of investments in scaling consumables sales to ensure long-term cash flow stability.

Analysis of competing companies

Dexcom (DXCM) - Total Debt to Equity Ratio|Aggregate Debt to Capital Penumbra Inc|Novanta Corp (NOVT) - Total Debt to Capital|All Debt to Shareholders' Equity Ratio Haemonetics Company (HAE)|INSP: Total Debt to Capital|procept-biorobotics.com - Debt to Capital|Debt to Equity CONMED (CNMD)|PLSE - All Debt to Shareholders' Equity Ratio|INMD: Total Debt to Capital|PMI (Picard Group) - Total Debt to Capital|Debt to Equity Surmodics, Inc. SRDX|Aggregate Debt to Equity Senseonics Corp|NeuroPace - Total Debt to Capital|Debt to Capital tactilemedical.com TCMD|Total Debt to Equity Ratio SNWV (SANUWAVE Health, Inc.)|OM - Total Debt to Capital|Total Debt to Equity Ratio Electromed Inc ELMD|LNSR - Aggregate Debt to Capital|AVITA Medical - Total Debt to Capital|Profound Medical (PROF) - Total Debt to Capital Coefficient|Total Debt to Capital BDMD|Total Debt to Equity Ratio EDAP Medical (EDAP)|Apyx Medical (APYX) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio ICCM (icecure-medical.com)|Pulmonx - Debt to Equity|Total Debt to Equity Ratio TELA Bio Inc. TELA|CTSO (CytoSorbents Corp.) - Total Debt to Capital|SRTS - Debt to Capital|Total Debt to Capital Zynex, Inc.|Vicarious Surgical (RBOT) - Debt to Equity Ratio|IINN: Total Debt to Capital|Total Debt to Capital Coefficient SeaStar Medical Holding Corporation|Total Debt to Capital IRIX (IRIDEX Corporation)|Total Debt to Equity Ratio ibs.inc (INBS)|Total Debt to Capital XAIR (Beyond Air)|profusa.com - Total Debt to Capital|SSKN - Debt to Equity|glucotrack.com (GCTK) - Debt to Equity|Total Debt to Equity Ratio NanoVibronix NAOV|Venus Concept Corporation (VERO) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital NUWE (Nuwellis, Inc.)|Debt to Capital AEMD|ASXC: Debt to Equity|Debt to Capital Ratio Avinger Inc. AVGR|Total Debt to Equity Ratio BSGM (BioSig Technologies, Inc.)|Total Debt to Capital Cutera Inc CUTR|Total Debt to Capital KNW (Know Labs, Inc.)|NARI: Total Debt to Capital Coefficient|Debt to Equity Nevro (NVRO)|RSLS (ReShape Lifesciences Inc.) - Aggregate Debt to Equity|Debt to Equity SILK